New Terocin Lotion
NDC Package 50488-1129-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

New Terocin (methyl salicylate, capsaicin, and menthol) lotions is wash and dry affected area. This formulation utilizes a lotion delivery system. Marketed by Alexso, Inc, this product is identified by NDC 50488-1129 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
50488-1129-1
Package Description
120 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
50488112901
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
120 ML
RxNorm Crosswalk
  • RxCUI: 1372464 - capsaicin 0.025 % / menthol 10 % / methyl salicylate 25 % Topical Lotion
  • RxCUI: 1372464 - capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion

Clinical Specifications

Proprietary Name
New Terocin
Non-Proprietary Name
Methyl Salicylate, Capsaicin, And Menthol
Substance Name
Capsaicin; Menthol; Methyl Salicylate
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Wash and dry affected area. Shake bottle well before each use and gently rubover area of pain. Use is not recommended more than four times a day. Washhands immediately afterwards to avoid contact with eyes.

Regulatory & Marketing

Labeler Name
Alexso, Inc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-13-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50488-1129-1 identifies a specific commercial package of 120 ml in 1 bottle of New Terocin, a human over the counter drug labeled by Alexso, Inc. This product is billed per "ML" milliliter and contains an estimated amount of 120 billable units per package. This lotion is formulated for topical use and contains capsaicin; menthol; methyl salicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alexso, Inc on March 13, 2013. The current certification is valid through December 31, 2026.

How is this Alexso, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50488112901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50488-1129-1
11-Digit CMS (5-4-2)
50488-1129-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.